Julia* called me with cautious excitement to let me know that she received the job offer of her dreams, as global workplace experience director at a leading consumer brand company. On one hand, she was ecstatic at reaching her goal to work for a recognized brand. Yet Julia’s reservation about the offer stemmed from the fact that it required her to relocate to the employer’s headquarters a thousand miles away. With two kids in elementary school, she didn’t want to move, but she also didn’t want to lose this opportunity. She needed to know how to negotiate the relocation issue.

As an angel investor in early-stage startups, I’ve long noticed my peers apparent bias toward the strength and character of the founding entrepreneurs, often overriding a strong solution to a painful problem with a big opportunity. In other words, the entrepreneur quality is more important than the idea -- in investor jargon, people invest in the jockey, and not the horse.

Image: https://blog.startupprofessionals.com

As return-to-work plans clash with rising COVID-19 cases in many states and the spread of the Delta variant, some tech giants are joining the growing chorus of companies requiring their employees to get vaccinated against the virus before coming into their offices.

The US Equal Employment Opportunity Commission has said employers can require employees to get a COVID-19 vaccine or bar them from the office.

People often associate the term “data literacy” with mastering a litany of technical skills: SQL for data querying, Python for data analysis and Tableau for data visualisation, to name a few. However, one skill that is less discussed and has great power to scale data-guided decision making across the organisation is far more basic, though not necessarily straightforward to learn: the ability to ask great questions of a data team.

CHAPEL HILL – COVID-19 has affected entrepreneurial funding in ways that will shape the economy for years to come. As businesses begin to look past the pandemic, a stark contrast in access to external capital is emerging. Although venture capital funding is extremely robust, many main street businesses face questionable futures as government support programs wind down. For both high-tech and main street businesses, the pandemic hit underserved communities and minority-owned businesses especially hard.

The delta variant spreads much faster than other Covid-19 strains—and scientists may now know why.

People infected with the delta variant have more than 1,260 times the viral load—the concentration of viral particles in the body—than those with the original strain found in China, a group of scientists has reported in a preprint paper. A higher viral load can have many implications such as more severe disease. Its most significant contribution is to a virus’s higher transmissibility.

Intuitively, many entrepreneurs and businesses believe that the key to faster growth and success is more products, features, and markets. Since we all have limited resources, and can’t add more hours to the day, the result is usually more things done poorly, rather than a few key things done better than anyone else. Every advisor and investor will tell you to keep your focus or spotlight.

Image: https://blog.startupprofessionals.com

As company leaders grapple with what a return to the office should look like, they should take the opportunity to think carefully about which parts of work should be done in person, which should be virtual, and which can benefit from a mix, then can design toward that ideal. The author offers six questions to ask as you plot out your team’s work plan. Given all that we’ve overcome throughout the past 15 months, it would be a shame if we didn’t take advantage of every single hard-earned pearl of wisdom around work, life, and the nexus of the two. Let’s harness our new perspectives on time, technology, and togetherness to rethink how we work — and specifically, how we gather.

Jeff Boyle, President of Ellume USA, joins Rich Bendis on BioTalk to chat about his history, their Flagship U.S. Manufacturing Facility in Frederick, MD, and why BioHealth Capital Region is a right fit for their company goals.

Listen now on Google https://bit.ly/3i0XFUO, Apple https://apple.co/2TDD1kg, Spotify https://spoti.fi/3kWwP1P, and TuneIn https://bit.ly/3BGPDrP

Each quarter we bring you an update from our Johnson & Johnson Innovation – JLABS Portfolio of companies across our 13 sites, from San Diego to Shanghai. Beyond news of our companies milestones, we also report on the diversity of our JLABS Portfolio leadership as we seek to reflect the patients we serve.

This past quarter JLABS @ Washington, DC opened its doors and welcomed the inaugural class of residents with areas of focus ranging from health equity to broad-spectrum antivirals. Housed at the new Children's National Research & Innovation Campus, JLABS @ Washington, DC also serves as the BLUE KNIGHT™ hub in collaboration with the Biomedical Advanced Research and Development Authority (BARDA). You can read more about our newest site in Fierce Biotech and you can always find our latest stats and companies via our JLABS Portfolio Navigator. Finally, don't forget to register to virtually join the JLABS @ Washington, DC Grand Opening celebration on September 22!

TUCSON, AZ / ACCESSWIRE / July 26, 2021 / Returning to its first in-person programming this fall, the Association of University Research Parks (AURP), a 35-year global non-profit membership organization serving university and institutional research park communities and innovation districts, announces the University of Utah Research Park is set once again to host AURP's 2021 International Conference, October 18-21, 2021, in Salt Lake City, UT.

The delta variant of SARS-CoV-2, the virus that causes COVID-19, is quickly spreading across the world. The World Health Organization estimates it will be the dominant strain globally within months, reports MarketWatch. In the United States, delta already is—and that’s a big problem, especially for the unvaccinated.

Image: Brian McGowan/Unsplash

Since first appearing in India in late 2020, the Delta variant of SARS-CoV-2 has become the predominant strain in much of the world. Researchers might now know why Delta has been so successful: people infected with it produce far more virus than do those infected with the original version of SARS-CoV-2, making it very easy to spread.

Embarking on an entrepreneurial journey is an adventure in itself or rather a rollercoaster ride. Not everyone who takes up entrepreneurship attains success. Nobody knows whether entrepreneurial characteristics are inborn or can be acquired, however, surely there are some qualities and traits that most successful entrepreneurs have in common. For instance, passion, self-confidence, decision-making ability, and other personal, mental and social traits.

Every one of you business owners I know has worked hard to build your brand, and recognizes the critical value of instant brand recognition and leadership. You have done everything to register your brand legally, including domains, copyrights, patents, and trademarks. Yet, as an outside advisor, I often see slippage over time on protecting your brand, which can be costly.

Image: https://blog.startupprofessionals.com

As the coronavirus sweeps across the globe in relentless waves, a succession of more-infectious strains has washed up. So far delta, the variant first reported in India in October, is the most worrisome. About twice as transmissible as the original virus that emerged in late 2019, delta combines a multitude of genetic features that have enabled it to pierce public-health defenses to stoke severe epidemics and trigger fresh rounds of movement restrictions or delay planned easings of them.

As the population fully vaccinated against COVID-19 grows, more employers are asking employees to come back into the office. But while some employees may welcome the return to on-site work, one-third of respondents in a new McKinsey survey1 said their return to work has had a negative impact on their mental health. Almost half of those who have not yet returned anticipate negative mental health impacts.

VANCOUVER, British Columbia--(BUSINESS WIRE)--Nextech AR Solutions Corp. (“Nextech'' or the “Company”) (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, AR-enhanced video conferencing and virtual events, today revealed plans to launch its NFT hologram creator platform. The creator platform will leverage the Company's human hologram creator platform HoloX, which is expected to launch in the third quarter. Once launched, customers will have the ability to seamlessly experience its digital collectibles in augmented reality.

The last two decades of technological transformation and globalization have created profound new challenges –and opportunities– for how and where innovation is located, organized, and capitalized. In this emerging global knowledge economy, the roles and responsibilities for invention, innovation, and entrepreneurship are being redefined and must be shared by the primary players; namely, universities, governments, corporations, and venture capital firms. From our perspective as a university, this begs the question: how do we ensure that exciting research is turned into profitable, real world solutions?  

As we mentioned in the early days of the pandemic, COVID-19 has been accompanied by a rise in cyberattacks worldwide. At the same time, the global response to the pandemic has accelerated interest in the collection, analysis, and sharing of data - specifically, patient data - to address urgent issues, such as population management in hospitals, diagnoses and detection of medical conditions, and vaccine development, all through the use of artificial intelligence (AI) and machine learning.